semaglutide bad side effects Wegovy & How to Avoid Them Ozempic (semaglutide) is a GLP-1

GLP-1 drugs for diabetes and weight loss have recently become blockbuster pharmaceuticals, with Lilly and Novo Nordisk leading the market

It often means finding the version that fits your current energy

Patent protection prevents generic manufacturers from producing lower-cost versions until exclusivity periods expire

This potential overlap makes understanding the ocular effects of diabetes medications particularly relevant for comprehensive patient management

A Pew Research Center survey conducted in February examined American attitudes toward weight-loss drugs and found that, while more than half of those familiar with the medications consider them a valuable weight loss option, 19% believe they are not, while 28% are unsure